Certain glucose-lowering meds associated with lower risk for COPD exacerbations
For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...
Study demonstrates feasibility, effectiveness of mobile care for COPD
A multimodal, digital community-based intervention was feasible and decreased illness-related distress in treating patients ...
Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported financial results for the fourth quarter and full ...